SNV-4818

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameSNV-4818
Drug Alias NameSNV-4818
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitors
TargetsPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynnovation Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPikavation Therapeutics IncSynnovation Therapeutics IncNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A